ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 294 filers reported holding ARGENX SE in Q2 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $94,155,108 | +9.3% | 218,945 | +0.0% | 1.61% | +19.3% |
| Q1 2024 | $86,168,378 | -7.8% | 218,857 | -11.0% | 1.35% | -11.5% |
| Q4 2023 | $93,498,662 | -40.8% | 245,771 | -23.5% | 1.53% | -46.3% |
| Q3 2023 | $157,987,759 | +23.2% | 321,355 | -2.3% | 2.84% | +31.0% |
| Q2 2023 | $128,250,789 | +4.7% | 329,076 | +0.0% | 2.17% | -3.6% |
| Q1 2023 | $122,547,523 | -1.6% | 328,916 | +0.0% | 2.25% | -8.5% |
| Q4 2022 | $124,584,686 | +10.5% | 328,867 | +3.0% | 2.46% | +10.7% |
| Q3 2022 | $112,764,000 | -6.8% | 319,400 | 0.0% | 2.22% | -14.3% |
| Q2 2022 | $121,014,000 | -7.0% | 319,400 | -22.6% | 2.59% | +27.0% |
| Q1 2022 | $130,065,000 | -10.0% | 412,500 | 0.0% | 2.04% | +10.4% |
| Q4 2021 | $144,453,000 | +43.6% | 412,500 | +23.9% | 1.85% | +39.2% |
| Q3 2021 | $100,566,000 | +0.3% | 333,000 | 0.0% | 1.33% | -1.6% |
| Q2 2021 | $100,256,000 | +70.1% | 333,000 | +55.6% | 1.35% | +54.3% |
| Q1 2021 | $58,933,000 | +25.2% | 214,000 | +33.8% | 0.87% | +20.9% |
| Q4 2020 | $47,054,000 | +12.0% | 160,000 | 0.0% | 0.72% | -12.2% |
| Q3 2020 | $42,003,000 | -29.4% | 160,000 | -39.4% | 0.82% | -36.4% |
| Q2 2020 | $59,461,000 | +51.8% | 264,000 | -11.2% | 1.29% | +2.0% |
| Q1 2020 | $39,163,000 | -17.9% | 297,300 | 0.0% | 1.27% | -5.7% |
| Q4 2019 | $47,723,000 | +82.1% | 297,300 | +29.3% | 1.34% | +55.3% |
| Q3 2019 | $26,211,000 | +21.0% | 230,000 | +50.3% | 0.87% | +31.4% |
| Q2 2019 | $21,662,000 | +13.4% | 153,000 | 0.0% | 0.66% | +0.3% |
| Q1 2019 | $19,101,000 | -21.7% | 153,000 | -39.8% | 0.66% | -39.2% |
| Q4 2018 | $24,402,000 | -4.0% | 254,000 | -24.2% | 1.08% | +15.8% |
| Q3 2018 | $25,406,000 | +206.6% | 335,000 | +235.0% | 0.93% | +171.2% |
| Q2 2018 | $8,286,000 | +3.0% | 100,000 | 0.0% | 0.34% | -8.8% |
| Q1 2018 | $8,044,000 | – | 100,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 273,343 | $106,529,967 | 17.42% |
| Kynam Capital Management, LP | 184,300 | $71,827,239 | 9.88% |
| Ikarian Capital, LLC | 132,100 | $51,483,333 | 8.20% |
| Avoro Capital Advisors LLC | 1,263,500 | $492,423,855 | 6.68% |
| Artia Global Partners LP | 46,438 | $18,098,282 | 6.24% |
| DCF Advisers, LLC | 25,700 | $10,016,061 | 5.29% |
| Bellevue Group AG | 923,284 | $359,831,473 | 5.13% |
| Eagle Health Investments LP | 64,400 | $25,098,612 | 4.69% |
| Paradigm Biocapital Advisors LP | 150,000 | $58,459,500 | 4.52% |
| Paradigm Biocapital Advisors LP | 142,259 | $55,442,600 | 4.28% |